338 BM-1252 (APG-1252): a potent dual specific Bcl-2/Bcl-xL...

European Journal of Cancer 2014 / 11 Vol. 50

338 BM-1252 (APG-1252): a potent dual specific Bcl-2/Bcl-xL inhibitor that achieves complete tumor regression with minimal platelet toxicity

Bai, L., Chen, J., Liu, L., McEachern, D., Aguilar, A., Zhou, H., Yang, C.Y., Wang, H., Wen, J., Wang, G., Zhai, Y., Guo, M., Yang, D., Wang, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70464-2
Date:
November, 2014
File:
PDF, 78 KB
english, 2014
Conversion to is in progress
Conversion to is failed